Ironwood Pharmaceuticals | IRWD - Market Capitalization


Ironwood Pharmaceuticals reported $601.1M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Almirall EUR 2.76B 472.53M Dec/2025
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amarin USD 290M 51M Dec/2025
Astellas Pharma JPY 4.56T 770.92B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Charles River Laboratories USD 7.85B 2.17B Mar/2026
Coherus Biosciences USD 172M 19M Dec/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 885M 351M Dec/2025
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Incyte USD 18.73B 660M Mar/2026
Karyopharm Therapeutics USD 1.05B 912M Jun/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Moderna USD 20.15B 8.53B Mar/2026
Pacira USD 915M 149M Mar/2026
PTC Therapeutics USD 5.64B 460M Mar/2026
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Takeda JPY 9.01T 1.37T Mar/2026
Ultragenyx Pharmaceutical USD 2.06B 159M Mar/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024